Activated RSK regulates epithelial cell motility and invasiveness by stimulating the gene expression of the uPA/uPA receptor33, and activated RSK in breast carcinoma enhances cellular invasion through phosphorylation of IκBα, allowing NF-κB to translocate into the nucleus and induce uPA expression34. This evidence concerns the gene RPS6KA3 and breast carcinoma.